1,333
Views
16
CrossRef citations to date
0
Altmetric
Editorial

New to Galleria mellonella

Modeling an ExPEC infection

Pages 371-374 | Received 18 Feb 2014, Accepted 24 Feb 2014, Published online: 25 Feb 2014
This article refers to:
In vivo correlates of molecularly inferred virulence among extraintestinal pathogenic Escherichia coli (ExPEC) in the wax moth Galleria mellonella model system

Pathogens and their respective hosts interact closely leading to the host–pathogen framework response that could result in different outcomes that range from pathogen elimination to death of the host. To improve our ability to propose new measures that promote pathogen elimination and prevent host death, we need to have a comprehensive understanding of this interaction. Generally, most hosts respond to molecular signs of a microbe invasion by initiating local defense mechanisms comprised of innate and acquired immune surveillance systems. Traditionally, established infection models such as mice, rats, hamsters, and cultured cells have been utilized for interrogating the host–pathogen relationship and identifying potential virulence factors. However, while whole animals are preferred over in vitro assessments and offer the possibility of studying both innate and adaptive immune responses, the use of members of the rodent family has its inherent problems such as costs, space requirements, and animal ethics policies.

Since the introduction of the nematode Caenorhabditis elegans as a model host for pathogenic bacteriaCitation1 and fungi,Citation2 both Drosophila melanogaster and the wax moth Galleria mellonella have also been exploited as suitable models (). To date, the fruit fly is probably the most versatile infection model as it is able to be infected by all classes of human pathogens, including virusCitation3 and parasitesCitation4 which cannot be modeled in C. elegans. In addition, D. melanogaster can be utilized in low to medium throughput drug screens for potential anti-fungal compounds.Citation5 Only a limited number of studies utilizing G. mellonella as a model organism have been reported off due to a lack of sufficient tools and available information such as annotated genome sequences, microarrays, mutant, or reporter strains as well as the ability to generate knockdowns or knockouts that are already readily available for mice, nematodes and fruit flies. Nevertheless, over the last few years G. mellonella has been utilized to study the pathogenic mechanisms of several key bacterial and fungal pathogens of humans which have produced results that correlate closely with those obtained from similar investigations using mammalian host models.Citation6 In contrast to the limitations listed above in using the wax moth as a model host, the insect antimicrobial defense system is much more advanced compared with worms and flies whereby hemolymph cells can phagocytose microbes and also induce the production of antimicrobial peptides and lysozyme.Citation7,Citation8 Furthermore, insect larval midgut epithelial cells share similar physiological phenotypes as intestinal cells of mammalian digestive systems. Further examples of the advantages in using G. mellonella larvae as a model host not achievable in other host models have also been documented. For example, larvae of G. mellonella can withstand temperatures up to 37 °C, similar to the body temperature of the human host, thus facilitating the study of microorganisms at this temperature. In addition, G. mellonella can be infected by the pathogen via different routes of infection which include topical application, parenteral delivery, and injection.Citation9

Table 1. Comparative characteristics of heterologous hosts used in host–pathogen interaction studies

G. mellonella larvae have been utilized in studies on pathogenesis of a wide range of microbial infections including human and plant fungi (Fusarium oxysporum, Aspergillus fumigatus, Candida albicans)Citation10,Citation11 and both gram-negative and gram-positive bacterial pathogens such as Staphylococcus aureus,Citation12,Citation13Pseudomonas aeruginosa,Citation14,Citation15Serratia marcescens,Citation16Enterococcus faecalis,Citation17Acinetobacter baumanii,Citation18 and Burkholderia pseudomallei.Citation19 Initial studies on Escherichia coliG. mellonella interaction were performed with non-pathogenic E. coli and it was not until 2012, when the wax moth was first reported as a suitable host to study pathogenic E. coli (EPEC).Citation20

The diversity of E. coli is well documented in terms of its genetics as well as the ability to live as either harmless commensals or pathogens in different animal and human hosts. Extraintestinal pathogenic E. coli (ExPEC) are facultative pathogens that usually exist as normal intestinal flora. However, ExPEC can migrate to other sites within the infected host and cause a variety of severe infections such as meningitis in newborns, urinary tract infections (UTI), and sepsis. ExPEC-induced infections are frequently reported mainly as a result of the pathogen’s ability to infect a broad host range. As a result of these infections, the impact is substantial in terms of costs of treatment and percentage of morbidity.Citation21 The pathogenic potential of ExPEC is attributed to the expression of virulence factors known to be required for the establishment of infection. Several prototypic ExPEC isolates and other E. coli strains have been fully sequenced and annotated. A number of studies that analyzed genome data together with epidemiological data have successfully confirmed that many known and putative virulence factors are shared between distinct ExPEC pathotypes (for a review see ref. Citation22). Among the virulence factors identified, secreted toxins such as α-hemolysin (HlyA) and cytotoxic necrotizing factor-1 disrupt host-signaling cascades that prevent host inflammatory responses. In addition, ExPEC also produces aerobactin, bacteriocin, and enterobactin, which sequester essential iron away from the host. ExPEC possess appendages such as pili or fimbriae with adhesive properties that mediate the initial interaction with host cells and tissues. When the ExPEC have successfully entered the cells and tissues, they are able to initiate colonization and avoid phagocytosis through the formation of a capsule.Citation23

Previously, virulence of ExPEC was established in the zebrafish model.Citation24 Wiles et al. utilized zebrafish embryos to model an ExPEC infection and were able to explain why infection by the pathogen results in a diverse array of virulence phenotypes in different locales within the infected host that mirror both localized or systemic infections. Furthermore, the authors were able to document additional evidence of phenotypic diversity between ExPEC strains, which was not obvious from genome sequence comparisons or achievable using other model hosts.

ExPEC strains express pathogen-specific virulence factors when compared with commensal and intraintestinal pathogenic E. coli. Diard et al.Citation25 utilized C. elegans to investigate the role of the different ExPEC virulence determinants. The authors noted that similar virulence determinants were responsible for pathogenesis in both the C. elegans infection model as well as in a murine model of ExPEC infection. Furthermore, a factorial analysis of correspondence indicated good correlation between the presence or absence of ExPEC associated virulence factors with virulence in the murine septicemia model previously described by Johnson et al.Citation26 Therefore, C. elegans was successfully established to model virulence determinants of ExPEC strains.

For some pathogens, virulence in G. mellonella has also been shown to correlate with both molecular virulence characteristics and pathogenicity in mammalian model systems.Citation27 To date however, no studies have assessed the efficacy of the G. mellonella model for studies of ExPEC pathogenicity. In this issue of Virulence, Williamson et al.Citation28 report on a study to investigate the in vivo correlation between virulence gene repertoire and virulence potential of ExPEC utilizing the G. mellonella animal model. Initially, the establishment of the G. mellonella–ExPEC infection model demonstrated that increasing concentrations of bacterial cells correlated with faster killing rates of infected larvae. This indicates that the presence of live ExPEC are required for killing of G. mellonella, an established feature for a number of bacterial pathogens in a C. elegans infection model. Of greater implication is the correlation between the number of virulence genes and larval survival as reflected by the significantly faster killing of larvae by ExPEC isolates with higher virulence scores compared with isolates with a lower virulence score. By successfully correlating genotypic and phenotypic virulence, they have provided proof-of-concept of the use of G. mellonella for future studies investigating ExPEC virulence and potential therapeutic targets. However, an assessment of the expression of these virulence determinants during the infection process would have provided further insights into the more critical virulence factors associated with an ExPEC infection phenotype. This would circumvent any erroneous assumption of a direct relationship between the absence and presence of a gene with observed killing rates as many factors could be, and probably are, involved in the pathogenesis of ExPEC. This has been highlighted by the authors themselves whereby different isolates with a similar number of virulence traits kill the animal at different rates.

As noted above, infection of the G. mellonella animals induces the secretion of antimicrobial peptides and lysozymes. In this respect, the data documented by Williamson et al.Citation28 also provide strong correlation of in vitro antimicrobial resistance with the in vivo response toward ExPEC infection in this model system. They go on to propose that the G. mellonella model can be adopted for future studies assessing antimicrobial efficacy against ExPEC strains prior to mammalian experimentation. One avenue that could be exploited is evaluating the native or recombinant forms of the G. mellonella lysozyme and associated small antimicrobial peptides for potential bactericidal or bacteriostatic activity toward a range of bacterial pathogens. This could be achieved by initially performing transcriptome analysis of infected moths as previously undertaken by Vogel et al.Citation29 and identifying typical antimicrobial peptides and lysozyme-like enzymes. These identified proteins and peptides could then be tested using standard microdilution tests.

Currently, the use of G. mellonella as a host to model infection and study the host-pathogen interaction is limited by various factors. In addition to those listed above, other limitations include lack of a standardized source of larvae or the equivalent of the Caenorhabditis Genetics Centre (CGC) raising concerns on different propagation conditions and genetic variation between wax moth populations and the effect on experimental outcomes.Citation6 In light of the increasing popularity of studying bacterial pathogenesis and identification of virulence factors in a Galleria model of infection, a concerted effort in establishing standardized moth propagation and maintenance as well as experimental protocols will have to be undertaken before reliable inter-laboratory data comparisons can be made confidently. Taking into account the suitability of G. mellonella to model an intestinal pathogen infection, this animal may prove to be the ideal host to study other intestinal flora that result in debilitating phenotypes.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

The author thanks Cin Kong for assistance during the preparation of the manuscript and acknowledges the Ministry of Science, Technology and Innovation, Malaysia for supporting the research utilizing C. elegans as a model host for bacterial pathogens.

10.4161/viru.28338

References

  • Tan MW, Mahajan-Miklos S, Ausubel FM. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci U S A 1999; 96:715 - 20; http://dx.doi.org/10.1073/pnas.96.2.715; PMID: 9892699
  • Mylonakis E. Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia 2008; 165:1 - 3; http://dx.doi.org/10.1007/s11046-007-9082-z; PMID: 18060516
  • Schneider D, Shahabuddin M. Malaria parasite development in a Drosophila model. Science 2000; 288:2376 - 9; http://dx.doi.org/10.1126/science.288.5475.2376; PMID: 10875925
  • Habayeb MS, Ekström J-O, Hultmark D. Nora virus persistent infections are not affected by the RNAi machinery. PLoS One 2009; 4:e5731; http://dx.doi.org/10.1371/journal.pone.0005731; PMID: 19478998
  • Giacomotto J, Ségalat L. High-throughput screening and small animal models, where are we?. Br J Pharmacol 2010; 160:204 - 16; http://dx.doi.org/10.1111/j.1476-5381.2010.00725.x; PMID: 20423335
  • Cook SM, McArthur JD. Developing Galleria mellonella as a model host for human pathogens. Virulence 2013; 4:350 - 3; http://dx.doi.org/10.4161/viru.25240; PMID: 23799664
  • Vodovar N, Acosta C, Lemaitre B, Boccard F. Drosophila: a polyvalent model to decipher host-pathogen interactions. Trends Microbiol 2004; 12:235 - 42; http://dx.doi.org/10.1016/j.tim.2004.03.007; PMID: 15120143
  • Dalhammar G, Steiner H. Characterization of inhibitor A, a protease from Bacillus thuringiensis which degrades attacins and cecropins, two classes of antibacterial proteins in insects. Eur J Biochem 1984; 139:247 - 52; http://dx.doi.org/10.1111/j.1432-1033.1984.tb08000.x; PMID: 6421577
  • Fuchs BB, O’Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1:475 - 82; http://dx.doi.org/10.4161/viru.1.6.12985; PMID: 21178491
  • Fuchs BB, Eby J, Nobile CJ, El Khoury JB, Mitchell AP, Mylonakis E. Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect 2010; 12:488 - 96; http://dx.doi.org/10.1016/j.micinf.2010.03.001; PMID: 20223293
  • Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842 - 50; http://dx.doi.org/10.1128/IAI.73.7.3842-3850.2005; PMID: 15972469
  • Desbois AP, Coote PJ. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. J Antimicrob Chemother 2011; 66:1785 - 90; http://dx.doi.org/10.1093/jac/dkr198; PMID: 21622972
  • Purves J, Cockayne A, Moody PC, Morrissey JA. Comparison of the regulation, metabolic functions, and roles in virulence of the glyceraldehyde-3-phosphate dehydrogenase homologues gapA and gapB in Staphylococcus aureus. Infect Immun 2010; 78:5223 - 32; http://dx.doi.org/10.1128/IAI.00762-10; PMID: 20876289
  • Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun 2003; 71:2404 - 13; http://dx.doi.org/10.1128/IAI.71.5.2404-2413.2003; PMID: 12704110
  • Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 2000; 182:3843 - 5; http://dx.doi.org/10.1128/JB.182.13.3843-3845.2000; PMID: 10851003
  • Chadwick JS, Caldwell SS, Chadwick P. Adherence patterns and virulence for Galleria mellonella larvae of isolates of Serratia marcescens. J Invertebr Pathol 1990; 55:133 - 4; http://dx.doi.org/10.1016/0022-2011(90)90044-7; PMID: 2405061
  • Michaux C, Sanguinetti M, Reffuveille F, Auffray Y, Posteraro B, Gilmore MS, Hartke A, Giard JC. SlyA is a transcriptional regulator involved in the virulence of Enterococcus faecalis. Infect Immun 2011; 79:2638 - 45; http://dx.doi.org/10.1128/IAI.01132-10; PMID: 21536798
  • Hornsey M, Wareham DW. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother 2011; 55:3534 - 7; http://dx.doi.org/10.1128/AAC.00230-11; PMID: 21502628
  • Thomas RJ, Hamblin KA, Armstrong SJ, Müller CM, Bokori-Brown M, Goldman S, Atkins HS, Titball RW. Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. Int J Antimicrob Agents 2013; 41:330 - 6; http://dx.doi.org/10.1016/j.ijantimicag.2012.12.009; PMID: 23402703
  • Leuko S, Raivio TL. Mutations that impact the enteropathogenic Escherichia coli Cpx envelope stress response attenuate virulence in Galleria mellonella. Infect Immun 2012; 80:3077 - 85; http://dx.doi.org/10.1128/IAI.00081-12; PMID: 22710873
  • Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123 - 40; http://dx.doi.org/10.1038/nrmicro818; PMID: 15040260
  • Dobrindt U, Hacker J. Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections. Curr Opin Microbiol 2008; 11:409 - 13; http://dx.doi.org/10.1016/j.mib.2008.09.005; PMID: 18824126
  • Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 2007; 4:134 - 63; http://dx.doi.org/10.1089/fpd.2007.0087; PMID: 17600482
  • Wiles TJ, Bower JM, Redd MJ, Mulvey MA. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog 2009; 5:e1000697; http://dx.doi.org/10.1371/journal.ppat.1000697; PMID: 20019794
  • Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, Taddei F, Denamur E, Matic I. Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect 2007; 9:214 - 23; http://dx.doi.org/10.1016/j.micinf.2006.11.009; PMID: 17208486
  • Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, Denamur E. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis 2006; 194:1141 - 50; http://dx.doi.org/10.1086/507305; PMID: 16991090
  • Chua KY, Seemann T, Harrison PF, Monagle S, Korman TM, Johnson PD, Coombs GW, Howden BO, Davies JK, Howden BP, et al. The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One 2011; 6:e25887; http://dx.doi.org/10.1371/journal.pone.0025887; PMID: 21991381
  • Williamson DA, Mills G, Johnson JR, Porter S, Wiles S. In vivo correlates of molecularly inferred virulence among extraintestinal pathogenic Escherichia coli (ExPEC) in the wax moth Galleria mellonella model system. Virulence 2014; 5:388 - 93; http://dx.doi.org/10.4161/viru.27912; PMID: 24518442
  • Vogel H, Altincicek B, Glöckner G, Vilcinskas A. A comprehensive transcriptome and immune-gene repertoire of the lepidopteran model host Galleria mellonella. BMC Genomics 2011; 12:308; http://dx.doi.org/10.1186/1471-2164-12-308; PMID: 21663692